2027 ICD-10-CM Diagnosis Code Z15.07Genetic susceptibility to malignant neoplasm of urinary tract
Z15.07 is a billable ICD-10-CM diagnosis code for genetic susceptibility to malignant neoplasm of urinary tract. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 951. The code is not accepted as a principal diagnosis by the Medicare Code Editor and exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Genetic susceptibility to disease.
Code Identity
Code Classification
Code EditsBilling
Medicare Code Editor checks that affect claim validity for Z15.07.
Present on Admission (POA)Billing
Z15.07 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review the other POA exempt codes in Genetic carrier and genetic susceptibility to disease (Z14-Z15).
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to Z15.07: its own notes plus those printed at Z15.0, Z15, and Chapter 21. A note printed at a category, block or chapter applies to every code under it.
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
Code First
The underlying condition named in the note is sequenced before this code.
Use Additional Code
Add a second code, after this one, to fully describe the condition.
- code, if applicable, for any personal history of malignant neoplasm (Z85.-)
Notes
General instructions on how these codes are used.
- Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:
- (a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination (immunization), or to discuss a problem which is in itself not a disease or injury.
- (b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury.
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name Z15.07, its category, or a range that includes it.
Use Additional Code 2
These codes say to use an additional code from the note, and Z15.07 is one of the codes named.
- Z40.0 Encounter for prophylactic surgery for risk factors related to malignant neoplasmscode to identify risk factor, such as genetic susceptibility to malignant neoplasm Z15.- names Z15.-, which includes this code
- Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levelsgenetic susceptibility to malignant neoplasm (cancer) (Z15.0-) names Z15.0-, which includes this code
Code Also 2
These codes say Z15.07 may also be needed to fully describe the condition. The note gives no sequencing direction.
- Q85.81 PTEN hamartoma tumor syndromeif applicable, genetic susceptibility to malignant neoplasm (Z15.0-) names Z15.0-, which includes this code
- QA1 Genetic disorders associated with neoplasms, not elsewhere classifiedgenetic susceptibility to malignant neoplasm by site (Z15.0-) names Z15.0-, which includes this code
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Code History & ChangesHistory
Replacement Z15.07 replaces the following previously assigned code(s):
- Z15.09 - Genetic susceptibility to other malignant neoplasm
Questions About Z15.07Overview
What is the ICD-10 code for genetic susceptibility to malignant neoplasm of urinary tract?
The ICD-10-CM code for genetic susceptibility to malignant neoplasm of urinary tract is Z15.07 (sometimes written as Z1507). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is Z15.07 (Genetic susceptibility to malignant neoplasm) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report genetic susceptibility to malignant neoplasm of urinary tract on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does Z15.07 group to?
On inpatient claims, genetic susceptibility to malignant neoplasm of urinary tract maps to MS-DRG 951 (other Factors Influencing Health Status), which carries a relative weight of 0.5574. Higher weights mean higher Medicare reimbursement.
Can Z15.07 be a principal diagnosis?
No. The Medicare Code Editor rejects this code as a principal diagnosis because genetic susceptibility to malignant neoplasm of urinary tract describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.
Is Z15.07 exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for genetic susceptibility to malignant neoplasm of urinary tract on inpatient claims. The code appears in the Genetic carrier and genetic susceptibility to disease (Z14-Z15) range of the CMS exempt list.